Chemotherapy Regimen And Pediatric Osteosarcoma Posted: 07-23-07 02:24am
Seventy-four patients were included in
this retrospective study and classified
according to the newly devised
classification based on clinical and
imaging studies. The overall survival rate
is 48%. The stage of the disease and the
treatment, including chemotherapy, are the
only prognostic factors significantly
influencing survival. The survival of
patients with osteosarcoma has improved
with chemotherapy, but new therapeutic
strategies should be found for different
stages of disease. The authors' newly
devised classification based on clinical
and imaging studies proved to be adequate.
